Log in
0 followers
ALX Oncology is a publicly traded, clinical-stage immuno-oncology company focused on helping patients fight cancer by developing therapies that block the CD47 checkpoint pathway and bridge the innate and adaptive immune system.
Industries
Headquarters
Stage
Employees
Links
Jaume Pons
10 members
7 members
6 members
BioMarin Pharmaceutical
23 followers
Adaptive Biotechnologies
11 followers
Agilent Technologies
60 followers
Regeneron
77 followers
Verve Therapeutics
53 followers
Discover companies